Clinical Development Director, Obesity/Cardiometabolic

Amgen Inc.; United States; Remote; USD 275,000 - 372,000; Full time

Benefits offered by this job

Retirement plan

Medical coverage

Dental coverage

Vision coverage

Bonus program

Stock options

Flexible work models

Job summary

Amgen Inc. is seeking a Clinical Development Director for Obesity/Cardiovascular to lead late-stage studies within AMG 133 programs. The role reports to the Global Development Lead and shapes the global evidence generation plan, study concepts, and regulatory interactions.

You will collaborate across functions to translate strategies into protocols, monitor trials, and contribute to safety, regulatory submissions, and publications.

Qualifications

• MD or DO degree from an accredited medical school.
• 3 years of clinical research experience.
• Experience in late-phase development in cardiometabolic or related areas.

Responsibilities

• Provide clinical/scientific input into development plans and study concepts.
• Translate clinical strategy into study protocols and related documents.
• Serve as medical monitor for ongoing trials and review data for regulatory readiness.
• Contribute to safety reviews, regulatory interactions, and scientific publications.

Skills

Clinical leadership

Regulatory knowledge

Communication skills

Cross-functional collaboration

GCP knowledge

Education

MD or DO degree

Job description

Amgen Inc. is seeking a Clinical Development Director for Obesity/Cardiovascular to lead late-stage studies within AMG 133 programs. The role reports to the Global Development Lead and shapes the global evidence generation plan, study concepts, and regulatory interactions.

You will collaborate across functions to translate strategies into protocols, monitor trials, and contribute to safety, regulatory submissions, and publications.